Mugglehead
Subscribe
GSK wins FDA approval for Hibsago in chronic hepatitis B

GSK wins FDA approval for Hibsago in chronic hepatitis B

The 24-week injection course targets eligible adults without cirrhosis, with boxed liver and platelet warnings.

Mining & Critical Minerals

Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.

View all

Health & Science

Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.

View all

Markets & Technology

Technology, computing, crypto and cannabis, and the listed companies moving in them.

View all

Energy

Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.

View all

Cannabis & Psychedelics

Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.

View all